Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04882202Recruiting
Randomised, double-blind trial in acute kidney injury (AKI) comparing Acetaminophen group with Placebo group (2 arms). Primary endpoint: Incidence of acute kidney injury at 7 days. Started Oct 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04882202.